Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial
about
Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaPregnant and Postpartum Women's Experiences and Perspectives on the Acceptability and Feasibility of Copackaged Medicine for Antenatal Care and PMTCT in Lesotho.HIV-free survival at 12-24 months in breastfed infants of HIV-infected women on antiretroviral treatmentA Systematic Review of Interventions to Reduce Maternal Mortality among HIV-Infected Pregnant and Postpartum WomenMultiple Overimputation to Address Missing Data and Measurement Error: Application to HIV Treatment During Pregnancy and Pregnancy OutcomesPostnatal HIV transmission in breastfed infants of HIV-infected women on ART: a systematic review and meta-analysis.Prevention of mother-to-child transmission of HIV: Postpartum adherence to Option B+ until 18 months in Western Uganda.Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study."I did not feel like a mother": the success and remaining challenges to exclusive formula feeding among HIV-positive women in BrazilEfficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: the Breastfeeding, Antiretrovirals and Nutrition study experience.Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, TanzaniaAdherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission.Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants.Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women.Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis.Quality, not just quantity: lessons learned from HIV testing in Salvador, BrazilEfficacy of WHO recommendation for continued breastfeeding and maternal cART for prevention of perinatal and postnatal HIV transmission in Zambia.Health outcomes of HIV-exposed uninfected African infantsAntiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding.HIV-1 concentrations in human breast milk before and after weaning.Efficacy of Six-Week Extended-Dose Nevirapine Varies by Infant Birth Weight with Greatest Relative Efficacy in Low Birth Weight Infants.Antiretroviral therapy provided to HIV-infected Malawian women in a randomized trial diminishes the positive effects of lipid-based nutrient supplements on breast-milk B vitaminsDelayed HIV detection among infants exposed to postnatal antiretroviral prophylaxis during breastfeeding.Time of HIV diagnosis in infants after weaning from breast milk.Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxisMaternal weight loss during exclusive breastfeeding is associated with reduced weight and length gain in daughters of HIV-infected Malawian women.Role of intestinal mucosal integrity in HIV transmission to infants through breast-feeding: the BAN studyPopulation-level effectiveness of PMTCT Option A on early mother-to-child (MTCT) transmission of HIV in South Africa: implications for eliminating MTCT.Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review.Cluster-Randomized Controlled Study of SMS Text Messages for Prevention of Mother-to-Child Transmission of HIV in Rural Kenya.Changes in soluble transferrin receptor and hemoglobin concentrations in Malawian mothers are associated with those values in their exclusively breastfed, HIV-exposed infants.The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV.HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana.Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa.Maternal and Breastmilk Viral Load: Impacts of Adherence on Peripartum HIV Infections Averted-The Breastfeeding, Antiretrovirals, and Nutrition Study.A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission.Editorial commentary: turning the tide on HIV in women and children: preventing breast-milk HIV transmission while increasing maternal life expectancy.
P2860
Q27014960-BF26F60E-9D37-4772-9BC6-B77FFFE20252Q27315901-EFA96E25-5A26-47F6-AA88-53F663AA996AQ28070420-A8878E10-E3B8-4B77-82F5-6DEC6E7B93F2Q30381808-640E2D20-04C6-40F7-A06B-0B65ABDE8792Q31070972-9DE010B1-A587-4E2D-A8EA-B2CFCA1C42DAQ33787641-E0FFA955-856D-46F9-86A0-8B24EFEB3EA6Q33852927-D9ACDA5D-9FC2-414D-A46C-9C0FD392C554Q33946645-313FFC7A-2C20-48AE-B621-3E6C460D63F9Q34193380-EA1E38B3-2C2E-46B7-AB49-409BAC100CCBQ34657178-2676B77A-201E-464F-B3E5-B1B6ED2E857CQ35163949-3CF72A15-7A87-4EF2-8851-008B6AEF98EEQ35357751-5550CF4D-A402-4FAB-A7C8-5612A8B6C624Q35423380-B7837471-0752-42C4-82A6-A533CA9A379DQ35542419-EB50773E-AB2C-4A9F-B5A6-1A7F0E1D9FC9Q35597592-E5D14AC9-24FD-4E41-98B0-F231340072AEQ35751105-DE9D5046-8712-4720-B399-9E1CF0327521Q35794875-5E4B21A3-86BB-4276-B9B0-FEDBC86E336AQ35815018-1AD3FF16-AB05-4EB2-86FE-FE4A1742617AQ35825690-9B1D2891-6A6D-4FB6-977E-2D9C79C187CDQ35863995-32F52410-782F-4675-857D-65598DD6BD30Q36020074-18458CD1-0F84-4C7F-990C-B454442EF881Q36149804-8052EC6F-E2F6-48AE-9356-99613EC70225Q36316323-E62227AA-FC72-411F-B3AE-C035A4513C10Q36335386-810BF6F2-0B0B-4EF3-8FF2-88E220C35C93Q36335404-3C89BDD6-8448-4D05-9F8F-9F9FE481AF2BQ36471547-82CE23FF-883C-4F12-8175-2CE53D0CAC8DQ36926296-AEEC0EB2-7B65-4A8B-BF87-A6EB071F58FEQ37037065-DFE46A9D-4408-4B96-B924-93719009998CQ37274571-3944DCEA-B50F-4B44-A7CA-0BCA7F675E0AQ37411773-AA2C1DF3-C822-4382-BDC1-D846B82CFFF2Q37526926-D4A88C11-0669-4AF4-9FAC-731F9850377EQ37590381-54D2FD3B-7035-4873-9633-9753ACD18F5AQ37630262-C99A807B-F9B2-4027-8BE7-2D14497BD891Q37703445-0B20A40B-9C15-4767-82CE-049C1AFF7FC5Q38647745-1EF90DD5-F54C-402C-B1AF-F503A98AEBF3Q39186563-A4899BEE-FF5F-4A09-87F3-9A65892BA27AQ42220633-ECBB3FB1-0D7C-438D-93FF-E18E827716F7Q44316398-FD3845C1-C05D-43A7-B6BD-B2608D69A25C
P2860
Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Maternal and infant antiretrov ...... AN randomised controlled trial
@en
type
label
Maternal and infant antiretrov ...... AN randomised controlled trial
@en
prefLabel
Maternal and infant antiretrov ...... AN randomised controlled trial
@en
P2093
P2860
P50
P1433
P1476
Maternal and infant antiretrov ...... AN randomised controlled trial
@en
P2093
Alice Soko
BAN study team
Caroline C King
Charles S Chasela
Deborah D Kamwendo
Dorothy S Sichali
Francis Martinson
Innocent A Mofolo
Irving Hoffman
Jeffrey B Wiener
P2860
P304
P356
10.1016/S0140-6736(12)60321-3
P407
P50
P577
2012-04-26T00:00:00Z